Vildagliptin: Difference between revisions
From Proteopedia
Jump to navigationJump to search
David Canner (talk | contribs) No edit summary |
David Canner (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
<applet load="" size="480" color="" frame="true" spin="on" Scene ="" align="right" caption="Vildagliptin, better known as Galvus | <applet load="" size="480" color="" frame="true" spin="on" Scene ="Vildagliptin/Vilda/1" align="right" caption="Vildagliptin, better known as Galvus"/> | ||
===Better Known as: Galvus=== | ===Better Known as: Galvus=== | ||
* Marketed | * Marketed by: Novartis | ||
* Major Indication: | * Major Indication: | ||
* Drug Class: | * Drug Class: | ||
* Date of FDA Approval (Patent Expiration): | * Date of FDA Approval (Patent Expiration): | ||
